4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0000899243-21-041838
10% owner acquired 2,602,264 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SV7 Impact Medicine Fund LP 10% owner | 2021-10-26 | Conversion | +998,544 | 998,544 | D: show line 1 in the form | ||
| SV7 Impact Medicine Fund LP 10% owner | 2021-10-26 | Conversion | +998,544 | 998,544 | I: show line 2 in the form | ||
| SV7 Impact Medicine Fund LP 10% owner | 2021-10-26 | Conversion | +302,588 | 1,301,132 | D: show line 3 in the form | ||
| SV7 Impact Medicine Fund LP 10% owner | 2021-10-26 | Conversion | +302,588 | 1,301,132 | I: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SV7 Impact Medicine Fund LP 10% owner | 2021-10-26 | Conversion · Series B Convertible Preferred Stock | −9,486,166 | 0 | D: show line 5 in the form | |||||
| SV7 Impact Medicine Fund LP 10% owner | 2021-10-26 | Conversion · Series B Convertible Preferred Stock | −9,486,166 | 0 | I: show line 6 in the form | |||||
| SV7 Impact Medicine Fund LP 10% owner | 2021-10-26 | Conversion · Series C Convertible Preferred Stock | −2,874,595 | 0 | D: show line 7 in the form | |||||
| SV7 Impact Medicine Fund LP 10% owner | 2021-10-26 | Conversion · Series C Convertible Preferred Stock | −2,874,595 | 0 | I: show line 8 in the form |
Loading xslF345X03/doc4.xml…